Cardiovascular Disease Research
The Child Cardiology unit at Medical Center Nora-Heart Ltd. focuses on pediatric heart failure caused by systemic left ventricular systolic dysfunction, aiming to improve outcomes for young patients.
- Evaluation of finerenone added to standard therapy
- Assessment of NT‑proBNP as a treatment response marker
- Safety monitoring in long‑term use
The program is conducted in Sofia, Bulgaria, and is supported by a dedicated investigator team.
Pediatric Heart Failure Therapeutics
Ongoing studies investigate how new medication can safely complement existing treatments for children with left ventricular systolic dysfunction, seeking to reduce disease burden and enhance quality of life.
- Long‑term safety profile of finerenone
- Impact on cardiac function biomarkers
- Integration with standard of care protocols
These non‑commercial trials aim to generate evidence that may guide future guidelines in pediatric cardiology.
